Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 505-511

  Díez, Juan J ^a   Iglesias, Pedro ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; THYROTROPIN;

ADULT; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC HYPERTENSION; DRUG BLOOD LEVEL; EUTHYROIDISM; FEMALE; GENDER; GOITER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL; VASCULAR DISEASE;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GOITER; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; OSMOLAR CONCENTRATION; RETROSPECTIVE STUDIES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84875204092     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04468.x     Document Type: Article

References (22)

1. Hecht, A., &, Gershberg, H., (1968) Diabetes mellitus and primary hypothyroidism. Metabolism, 17, 108-113.
2. Michalek, A.M., Mahoney, M.C., &, Calebaugh, D., (2000) Hypothyroidism and diabetes mellitus in an American Indian population. Journal of Family Practice, 49, 638-640.
3. Warren, R.E., Perros, P., Nyirenda, M.J., et al,. (2004) Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemical euthyroid patients with diabetes: implications for screening. Thyroid, 14, 853-857.
4. Perros, P., McCrimmon, R.J., Shaw, G., et al,. (1995) Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Medicine, 12, 622-627.
5. Chubb, S.A.P., Davis, W.A., Inman, Z., et al,. (2005) Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Freemantle diabetes study. Clinical Endocrinology, 62, 480-486.
6. Nathan, D.M., Buse, J.B., Davidson, M.B., et al,. (2009) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 52, 17-30.
7. Scheen, A.J., (2005) Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Safety, 28, 601-631.
8. Vigersky, R.A., Filmore-Nassar, A., &, Glass, A.R., (2006) Thyrotropin suppression by metformin. Journal of Clinical Endocrinology & Metabolism, 91, 225-227.
9. Isidro, M.L., Penín, M.A., Nemiña, R., et al,. (2007) Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine, 32, 79-82.
10. Cappelli, C., Rotondi, M., Pirola, I., et al,. (2009) TSH-lowering effect of metformin in type 2 diabetic patients. Diabetes Care, 32, 1589-1590.
11. Díez, J.J., &, Iglesias, P., (2012) An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes. Diabetic Medicine, DOI: 10.1111/j.1464-5491.2012.03687.x. [Epub ahead of print]
12. Díez, J.J., &, Iglesias, P., (2012) Subclinical hyperthyroidism in patients with type 2 diabetes. Endocrine, DOI 10.1007/s12020-012-9621-3. [Epub ahead of print]
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
14. Rotondi, M., Leporati, P., La Manna, A., et al,. (2009) Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? European Journal of Endocrinology, 160, 403-408.
15. Díez, J.J., &, Iglesias, P., (2011) Relationship between thyrotropin and body mass index in euthyroid subjects. Experimental and Clinical Endocrinology and Diabetes, 119, 144-150.
16. Cappelli, C., Pirola, I., Mittempergher, F., et al,. (2012) Morbid obesity in women is associated to a lower prevalence of thyroid nodules. Obesity Surgery, 22, 460-464.
17. Díez, J.J., Sánchez, P., &, Iglesias, P., (2011) Prevalence of thyroid dysfunction in patients with type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes, 119, 201-207.
18. Oleandri, S.E., Maccario, M., Rossetto, R., et al,. (1999) Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. Journal of Endocrinological Investigation, 22, 137-140.
19. Rotondi, M., Cappelli, C., Magri, F., et al,. (2011) Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Clinical Endocrinology, 75, 378-381.
20. Zhou, G., Myers, R., Li, Y., et al,. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation, 108, 1167-1174.
21. Owen, M.R., Doran, E., &, Halestrap, A.P., (2000) Evidence that metformin exerts it anti-diabetic effects through inhibition of the complex 1 of the mitochondrial respiratory chain. Biochemical Journal, 348, 607-614.
22. Krysiak, R., &, Okopien, B., (2011) Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. Clinical Endocrinology, 75, 404-406.